News
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Nate Chenenko, principal with Ducker Carlisle, dives into the metrics pharma companies can track today in order ...
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Nate Chenenko, principal with Ducker Carlisle, explains the meaning behind Scope 3 emissions, including why they ...
Kevin Chinn, vice president and head of the cell & gene therapy service line at Cencora, outlines why early planning, ...
Agreement allows educational institutions to access cold chain packaging solutions without the typical request for proposal ...
These innovations are revolutionizing pharmaceutical packaging by enhancing drug safety, combating counterfeiting, ensuring ...
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life ...
In the fourth part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, explains the market dynamics or stakeholder misalignments that need to be resolved in order for the next ...
In the fifth part of this roundtable discussion, a panel of KOLs explore how the chain of custody and chain of ownership are ...
In the third part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, outlines alternative reimbursement ...
In the first part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, describes the US payer ecosystem’s ...
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life ...
As new pricing and trade policies take shape, 60% of life sciences and healthcare executives anticipate business disruption, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results